冠状动脉慢性闭塞病变介入治疗器械及策略进展:2014年回顾
被引量:2
摘要
冠状动脉(冠脉)慢性闭塞病变(CTO)虽然是目前经皮冠脉介入治疗(PCI)领域的热点和难点,但是随着介入治疗器械的发展、操作技术和策略的规范,以及术者经验的积累,CTO病变介入治疗成功的比例正逐年升高[1]。本文就目前国内外CTO病变PCI治疗领域的最新动向,包括器械、操作和策略等作一回顾。
出处
《国际心血管病杂志》
2015年第1期1-5,共5页
International Journal of Cardiovascular Disease
参考文献13
-
1Tsuchikane E, Yamane M, Mutoh M, et al. Japanese multicenter registry evaluating the retrograde approach for chronic coronary total occlusion [J ]. Catheter Cardiovasc lnterv, 2013,82(5) : E654-E661.
-
2Srivatsa SS, Edwards WD, Boos CM, et al. Histologic correlates of angiographic chronic total coronary artery occlusions: influence of occlusion duration on neovascular channel patterns and intimal plaque composition [ J ]. J Am Coil Cardiol, 1997,29(5) :955-963.
-
3Brilakis ES, Karmpaliotis D, Werner GS, et al. Developments in coronary chronic total occlusion percutaneous coronary interventions: 2014 state obthe art update [ J ]. J lnvasive Cardiol,2014,26(6) :261-266.
-
4Mozid AM, Davies JR, Spratt JC. The utility of a guideliner catheter in retrograde percutaneous coronary intervention of a chronic total occlusion with reverse cart-the " capture" technique[J]. Catheter Cardiovasc Interv, 2014, 83 (6): 929-932.
-
5Wu EB, Ikari Y. Stingray balloon used in slender percutaneous coronary intervention for chronic total occlusion [J ]. J lnvasive Cardiol,2013,25(7) :E155-E158.
-
6Mogabgab O, Patel VG, Michael TT, et al. Long term outcomes with use of the Cross Boss and Stingray coronary CTO crossing and re-entry devices[J]. J Invasive Cardiol, 2013,25 (11) :579-585.
-
7Dai J, Katoh O, Kyo E, et al. Approach for chronic total occlusion with intravascular ultrasound guided reverse controlled antegrade and retrograde tracking technique; single center experience[J]. J Interv Cardiol, 2013,26 (5) : 434-443.
-
8Brilakis ES, Karmpaliotis D, Vo MN, et al. Advances in the management of coronary chronic total occlusions [J ]. J Cardiovasc Transl Res, 2014,7 (4) ; 426-436.
-
9Sakakura K, Nakano M, Otsuka F, et al. Comparison of pathology of chronic total occlusion with and without coronary artery bypass graft[J]. Eur Heart J,2014,35(25) ; 1683-1693.
-
10Muramatsu T, Tsukahara R, Ito Y, et al. Changing strategies of the retrograde approach for chronic total occlusion during the past 7 years [J]. Catheter Cardiovasc Interv, 2013, 81 ( 4 ) : E178-E185.
同被引文献10
-
1辜小芳,王玉玲.医院介入导管室存在的问题及其应对策略[J].中国药业,2012,21(3):37-39. 被引量:5
-
2贾亮亮,柯永胜.药物洗脱支架与冠状动脉旁路移植术治疗无保护左主干病变的疗效比较[J].国际心血管病杂志,2013,40(1):31-33. 被引量:2
-
3刘姝莉.导管室存在的问题及应对策略[J].医学信息,2013(8):52-53. 被引量:1
-
4Zhang Yaojun,Chen Fang,Takashi Muramatsu,Xu Bo,Li Zhanquan,Ge Junbo,He Qing,Yang Zhijian,Li Shumei,Wang Lefeng,Wang Haichang,He Ben,Li Kang,Qi Guoxian,Li Tianchang,Zeng Hesong,Peng Jianjun,Jiang Tieming,Zeng Qiutang,Zhu Jianhua,Fu Guosheng,Christos V. Bourantas,Patrick W. Serruys,Huo Yong.Nine-month angiographic and two-year clinical follow-up of polymer-free sirolimus-eluting stent versus durable-polymer sirolimus-eluting stent for coronary artery disease: the Nano randomized trial[J].Chinese Medical Journal,2014(11):2153-2158. 被引量:8
-
5辛丽雅,许珏.无锡市三级甲等医院手术室医护人员亚健康状态与职业损伤状况[J].职业与健康,2018,34(14):1887-1890. 被引量:12
-
6刘江萍,木胡牙提.急性冠脉综合征流行病学及危险因素的研究进展[J].国际心血管病杂志,2019,46(1):1-3. 被引量:51
-
7胡盛寿,高润霖,刘力生,朱曼璐,王文,王拥军,吴兆苏,李惠君,顾东风,杨跃进,郑哲,陈伟伟,代表中国心血管病报告编写组.《中国心血管病报告2018》概要[J].中国循环杂志,2019,34(3):209-220. 被引量:3434
-
8李晓冉,王剑飞,李俊峡.冠状动脉病变介入治疗器械进展——微导管篇[J].中国循证心血管医学杂志,2019,11(8):897-899. 被引量:5
-
9刘兆平,霍勇.中国冠心病介入治疗发展现状:质量管理[J].中国医学前沿杂志(电子版),2021,13(3):31-33. 被引量:6
-
10葛均波.冠脉再狭窄病变的预测及介入治疗进展[J].海南医学,2002,13(12):13-14. 被引量:1
引证文献2
-
1刘慧竹,张瑞岩.影响药物洗脱支架置入术后新生内膜生成的因素[J].国际心血管病杂志,2015,42(5):316-319. 被引量:2
-
2王根洪,张鹏朝,吴朝霞,姚潇宇,李佳,雷建君.一种心脏介入手术医用推车的研制[J].中国医学装备,2022,19(4):206-208. 被引量:1
二级引证文献3
-
1杨杰,付锋,吴顶锋.CT定量评估易损斑块与颈动脉支架内再狭窄的相关性[J].陕西医学杂志,2016,45(8):962-963. 被引量:1
-
2张浩天,张瑞岩.糖尿病冠心病患者支架置入后内膜修复研究现状[J].国际心血管病杂志,2017,44(4):193-195. 被引量:2
-
3肖文玲,陈洁春,罗桂元.移动式多功能干燥工作台在复用精密贵重器械再处理中的应用效果[J].中国社区医师,2024,40(22):157-159.
-
1杨跃进.经皮冠状动脉介入治疗的并发症及其防治[J].上海医学,2003,26(3):165-167. 被引量:17
-
2曾勇,朱文玲,黄超联,沈珠军,张抒扬,郭丽琳,倪超,方理刚.慢性闭塞病变介入治疗对患者左心室射血分数和室壁运动的影响[J].中华心血管病杂志,2004,32(1):76-76. 被引量:2
-
3郑朝阳,陈秋雄,盛小刚,李新梅,王侠.冠状动脉慢性闭塞病变介入治疗安全性及疗效分析[J].广东医学,2008,29(12):2073-2073.
-
4郝六一,裴世炜,李学信.冠状动脉慢性闭塞病变介入治疗临床分析[J].实用心脑肺血管病杂志,2011,19(1):84-85. 被引量:1
-
5万海燕,王人彭,熊辉,游斌权.介入治疗对冠状动脉慢性闭塞病变患者的远期效果[J].中国康复理论与实践,2005,11(9):744-745.
-
6杨莉,曾运红.脂蛋白(a)与经皮冠状动脉介入治疗的相关性研究进展[J].医学综述,2014,20(18):3292-3294.
-
7刘志辉,王平.经皮冠状动脉介入术对冠状动脉慢性闭塞病变患者心功能的影响[J].山东医药,2012,52(47):37-38. 被引量:3
-
8吴哲兵,魏运亮,段继豪,李春生,代升平,潘金生,丰冠鹏.盐酸替罗非班用于冠状动脉慢性闭塞病变介入治疗的临床观察[J].实用医药杂志,2012,29(3):206-207. 被引量:1
-
9窦克非,丰雷.冠状动脉慢性闭塞病变介入治疗的合理性及其治疗策略[J].中国循环杂志,2016,31(12):1157-1159. 被引量:6
-
10杨清,杨晓利,李臻,于秀清,李绍彩,李艳军,王建龙.经桡动脉SAL指引导管处理右冠状动脉慢性闭塞病变一例[J].中国介入心脏病学杂志,2013,21(6):405-406. 被引量:2